On October 24th, President Trump signed a package of bills designed to confront and combat the nation’s opioid epidemic. On November 2nd, the FDA approved Dsuvia.
As the opioid epidemic continues to wreak havoc on the United States, we take a look at the viability of cannabidiol as an alternative.
Despite campaigns by the therapy community, and the government, to loosen the grip of opioids in the U.S., patients still expect them after surgery.
Landmark legislation to fight the opioid epidemic, supported by the APTA, is headed to the President’s desk to be signed into law.
Physical therapy is a viable alternative to opioid use. Yet, nearly 48,000 Americans died due to opioid related overdoses last year.
More than 115 Americans die every day from opioid-related causes. The SUPPORT for Patients and Communities Act, which passed in the House last week, aims to stop that.
New research has found that physicians modestly reduced the volume of opioids they prescribed after being told one of their patients had died of an overdose.
Opioid manufacturers, drug distributors, and pharmacy chains continue to get hit with lawsuits alleging they fueled the nation’s opioid crisis through deceptive marketing and negligence.
The lawsuit by South Carolina Attorney General Alan Wilson, filed in Richland County Court of Common Pleas in Columbia, accuses the company of the unfair and deceptive marketing of opioid painkillers.
The crackdown on opioid-related cases was reported as part of the Justice Department’s annual announcement of health care fraud enforcement efforts.